Company / Total Assets
Intellia Therapeutics, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$842.1M
FY2025
5-year range
$842.1M / $1.5B
FY2021-FY2025
Trend
-29.3%
vs FY2024
Sector context
#125 of 166
Health Care
What the data says
Intellia Therapeutics, Inc.'s total assets of $842M is lower than 75% of companies in the Health Care sector (FY2025). Total Assets has declined for 3 consecutive years, from $1.5B in FY2022 to $842M in FY2025.
Based on SEC 10-K filings.
$842M in FY2025 with a 5-year CAGR of +4.5%.
Declined from $1.3B to $842M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -17.9%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 166This company $842.1M Sector average $15.0B
▼
-94.4% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s total assets has declined for 3 consecutive years.
- 5-year CAGR of +4.5%, indicating consistent growth.
- In FY2025, total assets decreased 29.3% year-over-year.
- Ranks #125 out of 166 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $842.1M | -29.3% |
| FY2024 | $1.2B | -8.5% |
| FY2023 | $1.3B | -14.4% |
| FY2022 | $1.5B | +17.4% |
| FY2021 | $1.3B | +91.4% |
| FY2020 | $676.3M | +102.3% |
| FY2019 | $334.3M | -3.8% |
| FY2018 | $347.3M | -7.7% |
| FY2017 | $376.2M | +25.8% |
| FY2016 | $299.0M | +264.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026